This chapter describes the market for pharmaceuticals, which exceeded $500 million in sales in 2010. The industry is … marketing, which we summarize. We next describe the industry's market structure. Large, fully integrated, multinational firms … research and incentives for innovation. We then summarize the pricing and marketing of drugs in the US and several other …

market. Additionally, the estimation of the demand model suggests that the substitution rules and promotional efforts …

monthly data for pharmaceuticals prescribed from 1997 to 2005. The simulation indicates that the regulation of prices is …

Pharmaceuticals in the environment and public water supplies are believed to have serious impacts on human and … human health effects. Other studies more conclusively show that even minute concentrations of pharmaceuticals in the … awareness about the lack of governmental attention to the growing problem pharmaceuticals and pharmaceutical residues pose to …

. Estimation is done both at the aggregate level and at a country-specific level. By using a Bayesian panel probit model we deal …

advantage over the second and the third entrants, after controlling for differences in marketing activities. We also find …

The zero-for-zero initiative on pharmaceuticals contributed to both the substantial increase in U.S. pharmaceutical … initiative, the United States and its major trading partners reciprocally removed tariffs on many pharmaceuticals, their … derivatives, and certain chemical intermediates used to make pharmaceuticals …